Vanguard Group Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Vanguard Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.12 - $0.64 $67,682 - $360,972	564,020 Added 6.44%	9,317,838 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.41 $4,008 - $13,694	33,400 Added 0.38%	8,753,818 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.72 $13,909 - $28,614	-39,742 Reduced 0.45%	8,720,418 $3.14 Million
Q1 2023 May 15, 2023	BUY	$0.39 - $0.6 $59,919 - $92,183	153,639 Added 1.79%	8,760,160 $4.12 Million
Q4 2022 Feb 10, 2023	BUY	$0.46 - $42.69 $81,119 - $7.53 Million	176,347 Added 2.09%	8,606,521 $4.3 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $10,143 - $531,300	16,100 Added 0.19%	8,430,174 $5.36 Million
Q2 2022 Aug 12, 2022	BUY	$0.63 - $0.96 $333,367 - $507,988	529,155 Added 6.71%	8,414,074 $6.65 Million
Q1 2022 May 13, 2022	SELL	$0.5 - $1.06 $23,798 - $50,451	-47,596 Reduced 0.6%	7,884,919 $6.34 Million
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.22 $47,300 - $62,725	51,414 Added 0.65%	7,932,515 $8.01 Million
Q3 2021 Nov 12, 2021	BUY	$0.67 - $1.51 $5,787 - $13,043	8,638 Added 0.11%	7,881,101 $10.2 Million
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.1 $5.9 Million - $8.66 Million	7,872,463 New	7,872,463 $6.1 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.